1. Home
  2. ZNB vs ADTX Comparison

ZNB vs ADTX Comparison

Compare ZNB & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zeta Network Group Class A Ordinary Shares

ZNB

Zeta Network Group Class A Ordinary Shares

N/A

Current Price

$0.62

Market Cap

1.8M

ML Signal

N/A

Logo Aditxt Inc.

ADTX

Aditxt Inc.

HOLD

Current Price

$0.85

Market Cap

2.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZNB
ADTX
Founded
N/A
2017
Country
United States
United States
Employees
47
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
2.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ZNB
ADTX
Price
$0.62
$0.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
3.0M
Earning Date
N/A
11-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,945.00
Revenue This Year
N/A
$15,768.94
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$0.81
52 Week High
N/A
$6,412.72

Technical Indicators

Market Signals
Indicator
ZNB
ADTX
Relative Strength Index (RSI) 41.60 34.49
Support Level $0.56 $0.81
Resistance Level $0.66 $1.33
Average True Range (ATR) 0.08 0.26
MACD 0.01 -0.06
Stochastic Oscillator 11.64 3.84

Price Performance

Historical Comparison
ZNB
ADTX

About ZNB Zeta Network Group Class A Ordinary Shares

Zeta Network Group is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

Share on Social Networks: